文献速递关节外科

初次全膝关节置换术后假体周围关节感染风险:所有术前皮质类固醇注射都一样吗?

Periprosthetic Joint Infection Risk After Primary Total Knee Arthroplasty: Are All Preoperative Corticosteroid Injections the Same?
PubMed 文献 · J Arthroplasty · 2023-11-02

研究基于2009至2019年85,073例初次全膝关节置换患者数据,其中1,092例(1.3%)在术前90天内接受同侧关节内皮质类固醇注射。经倾向评分匹配和多因素逻辑回归分析发现,接受任何皮质类固醇注射者假体周围关节感染率显著高于对照组(1.6% vs 0.41%,P<.001),该差异主要由甲泼尼龙醋酸酯和倍他米松驱动,而曲安奈德和地塞米松未见显著升高。

要点

  • 术前90天内接受任何皮质类固醇注射者假体周围关节感染率为1.6%,显著高于对照组的0.41%(P<.001)。
  • 甲泼尼龙醋酸酯组感染率为1.7%(P=.003),倍他米松组为2.6%(P=.01),均显著高于对照组。
  • 曲安奈德组感染率为1.2%(P=.08),地塞米松组为0.0%(P=1),均无显著升高。

核心结论

  • 研究结果提示假体周围关节感染风险随皮质类固醇注射类型而异。
  • 在该大型数据库研究中,仅术前90天内接受甲泼尼龙醋酸酯或倍他米松注射的患者假体周围关节感染率显著高于对照组。

研究设计与样本

  • 研究为基于大型国家数据库的回顾性分析,纳入2009至2019年85,073例初次全膝关节置换患者。
  • 其中1,092例(1.3%)在术前90天内接受同侧关节内皮质类固醇注射,采用1:4倾向评分匹配后以多因素逻辑回归比较,主要结局为假体周围关节感染。

主要发现

  • 术前90天内接受任何皮质类固醇注射者假体周围关节感染率为1.6%,显著高于对照组的0.41%(P<.001)。
  • 甲泼尼龙醋酸酯组(n=543)感染率为1.7%,显著高于对照组(P=.003)。
  • 倍他米松组(n=153)感染率为2.6%,显著高于对照组(P=.01)。
  • 曲安奈德组(n=342)感染率为1.2%,与对照组无显著差异(P=.08)。
  • 地塞米松组(n=54)感染率为0.0%,与对照组无显著差异(P=1)。

关键数值与推荐

  • 术前90天内接受任何皮质类固醇注射者假体周围关节感染率为1.6%,对照组为0.41%(P<.001)。
  • 甲泼尼龙醋酸酯组感染率为1.7%(P=.003),倍他米松组为2.6%(P=.01)。
  • 曲安奈德组感染率为1.2%(P=.08),地塞米松组为0.0%(P=1)。
  • 所有药物在术前超过90天注射时,假体周围关节感染风险与对照组相当(0.51% vs 0.34%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous evidence has demonstrated an increased risk of periprosthetic joint infection (PJI) following primary total knee arthroplasty (TKA) in patients receiving corticosteroid injection (CSI) within 3 months of surgery. The study aimed to determine if PJI risk after TKA varied among different corticosteroid agents. METHODS: A total of 85,073 patients undergoing primary TKA from 2009 to 2019 were identified from a large national database. Of these, 1,092 (1.3%) received an ipsilateral, intra-articular CSI within 90 days of TKA. These patients were compared to those not receiving CSI using multivariate logistic regressions following 1:4 propensity score matching, with PJI development as the primary outcome. RESULTS: Patients given an injection of any corticosteroid within 90 days of TKA had significantly higher PJI rates compared to controls (1.6 versus 0.41%; P < .001). This finding was driven by patients receiving methylprednisolone acetate (n = 543) or betamethasone (n = 153), with prevalence rates of 1.7 and 2.6%, respectively (P = .003 and P = .01, respectively). No significant increase in the rate of PJI was observed for patients receiving triamcinolone (1.2%; P = .08; n = 342) or dexamethasone (0.0%; P = 1; n = 54) within 90 days preceding TKA. PJI risk for all agents, administered more than 90 days preoperatively normalized to control levels (0.51 versus 0.34%). CONCLUSIONS: These results suggest that PJI risk varies with CSI type. In this large database study, only patients given methylprednisolone acetate or betamethasone injections within 90 days of surgery had significantly higher PJI rates compared to controls.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Muffly BT, Ayeni AM, Jones CA, et al. Periprosthetic Joint Infection Risk After Primary Total Knee Arthroplasty: Are All Preoperative Corticosteroid Injections the Same? J Arthroplasty. 2023. PMID: 37924991. doi:10.1016/j.arth.2023.10.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。